Beacon Investment Advisors LLC Takes Position in Waters Co. (NYSE:WAT)

Beacon Investment Advisors LLC purchased a new stake in Waters Co. (NYSE:WATFree Report) in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 722 shares of the medical instruments supplier’s stock, valued at approximately $238,000.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Annis Gardner Whiting Capital Advisors LLC bought a new stake in shares of Waters in the third quarter worth $33,000. Exchange Traded Concepts LLC bought a new stake in shares of Waters in the fourth quarter worth $35,000. VisionPoint Advisory Group LLC lifted its position in shares of Waters by 300.0% in the third quarter. VisionPoint Advisory Group LLC now owns 144 shares of the medical instruments supplier’s stock worth $39,000 after purchasing an additional 108 shares in the last quarter. Wetzel Investment Advisors Inc. bought a new stake in shares of Waters in the fourth quarter worth $39,000. Finally, Turtle Creek Wealth Advisors LLC bought a new stake in shares of Waters in the fourth quarter worth $41,000. Institutional investors and hedge funds own 94.01% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on WAT shares. Robert W. Baird cut their price objective on shares of Waters from $319.00 to $312.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 8th. Jefferies Financial Group began coverage on shares of Waters in a research report on Monday, June 3rd. They set a “hold” rating and a $320.00 price target on the stock. Evercore ISI upped their price target on shares of Waters from $320.00 to $340.00 and gave the stock an “in-line” rating in a research report on Thursday, April 4th. TD Cowen upped their price target on shares of Waters from $350.00 to $358.00 and gave the stock a “hold” rating in a research report on Wednesday, May 8th. Finally, Barclays dropped their price target on shares of Waters from $300.00 to $295.00 and set an “underweight” rating on the stock in a research report on Wednesday, May 8th. One analyst has rated the stock with a sell rating and eleven have issued a hold rating to the company. Based on data from MarketBeat, Waters has an average rating of “Hold” and an average target price of $307.20.

Check Out Our Latest Report on WAT

Waters Stock Performance

Shares of NYSE:WAT traded up $1.54 on Friday, hitting $302.09. The company had a trading volume of 453,576 shares, compared to its average volume of 518,595. Waters Co. has a 1-year low of $231.90 and a 1-year high of $367.21. The stock has a market cap of $17.92 billion, a price-to-earnings ratio of 29.65, a P/E/G ratio of 4.79 and a beta of 0.97. The stock has a 50 day moving average price of $327.55 and a 200 day moving average price of $322.57. The company has a current ratio of 1.94, a quick ratio of 1.30 and a debt-to-equity ratio of 1.60.

Waters (NYSE:WATGet Free Report) last released its quarterly earnings data on Tuesday, May 7th. The medical instruments supplier reported $2.21 EPS for the quarter, beating the consensus estimate of $2.10 by $0.11. Waters had a net margin of 20.75% and a return on equity of 66.59%. The firm had revenue of $636.80 million for the quarter, compared to the consensus estimate of $635.57 million. During the same period in the previous year, the company earned $2.49 earnings per share. The company’s quarterly revenue was down 7.0% on a year-over-year basis. Analysts expect that Waters Co. will post 11.85 EPS for the current year.

Insider Activity at Waters

In other Waters news, Director Richard H. Fearon purchased 1,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 28th. The shares were acquired at an average cost of $332.90 per share, for a total transaction of $332,900.00. Following the completion of the purchase, the director now owns 1,653 shares of the company’s stock, valued at approximately $550,283.70. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In other Waters news, Director Linda Baddour sold 500 shares of the stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price of $355.54, for a total transaction of $177,770.00. Following the sale, the director now directly owns 2,250 shares in the company, valued at $799,965. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Richard H. Fearon acquired 1,000 shares of Waters stock in a transaction on Tuesday, May 28th. The shares were purchased at an average price of $332.90 per share, for a total transaction of $332,900.00. Following the completion of the purchase, the director now directly owns 1,653 shares of the company’s stock, valued at $550,283.70. The disclosure for this purchase can be found here. 0.82% of the stock is currently owned by corporate insiders.

Waters Company Profile

(Free Report)

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Recommended Stories

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WATFree Report).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.